Cadre Holdings, Inc. (CDRE) stock
CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3024% above fair value
$32.41+0.31 (+0.97%)
Close on Nov 17, 2026Market cap $1.39BP/E 40.0Yield 1.17%
Cadre price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cadre's price to sales ratio was 2.1× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 1.4× to 3.1×, with a median of 2.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.1× | −0.6 |
| 2025 | Dec 31, 2025 | 2.7× | +0.1 |
| 2024 | Dec 31, 2024 | 2.5× | −0.0 |
| 2023 | Dec 29, 2023 | 2.6× | +0.8 |
| 2022 | Dec 30, 2022 | 1.7× | +0.1 |
| 2021 | Dec 31, 2021 | 1.6× | – |
See a number that looks wrong?